Skip to main content
Advertisement
  • Other Publications
    • EMBO Press
    • The EMBO Journal (Home)
    • EMBO reports
    • EMBO Molecular Medicine
    • Molecular Systems Biology
    • Life Science Alliance
Login

   

Search

Advanced Search

Journal

  • Home
  • Latest Online
  • Current Issue
  • Archive
  • Subject Collections
  • Review Series & Focuses

Authors & Referees

  • Submit
  • Author Guidelines
  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Bibliometrics
  • Referee Guidelines
  • Open Access Charges

Info

  • E-Mail Editorial Office
  • Alerts
  • RSS Feeds
  • Subscriptions & Access
  • Reprints & Permissions
  • Advertise & Sponsor
  • Media Partners
  • News & Press
  • Recommend to Librarian
  • Customer Service
  • Home
  • The EMBO Journal: 25 (13)

Recruitment of PRC1 function at the initiation of X inactivation independent of PRC2 and silencing

Stefan Schoeftner, Aditya K Sengupta, Stefan Kubicek, Karl Mechtler, Laura Spahn, Haruhiko Koseki, Thomas Jenuwein, Anton Wutz
DOI 10.1038/sj.emboj.7601187 | Published online 08.06.2006
The EMBO Journal (2006) 25, 3110-3122
Stefan Schoeftner
Research Institute of Molecular Pathology, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aditya K Sengupta
Research Institute of Molecular Pathology, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Kubicek
Research Institute of Molecular Pathology, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl Mechtler
Research Institute of Molecular Pathology, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Spahn
Centre of Molecular Medicine, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haruhiko Koseki
RIKEN Research Center for Allergy and Immunology (RCAI), RIKEN Yokohama Institute, Suehiro, Tsurumi‐ku, Yokohama, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Jenuwein
Research Institute of Molecular Pathology, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anton Wutz
Research Institute of Molecular Pathology, Vienna, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Author Affiliations

  1. Stefan Schoeftner1,
  2. Aditya K Sengupta1,
  3. Stefan Kubicek1,
  4. Karl Mechtler1,
  5. Laura Spahn2,
  6. Haruhiko Koseki3,
  7. Thomas Jenuwein1 and
  8. Anton Wutz*,1
  1. 1 Research Institute of Molecular Pathology, Vienna, Austria
  2. 2 Centre of Molecular Medicine, Vienna, Austria
  3. 3 RIKEN Research Center for Allergy and Immunology (RCAI), RIKEN Yokohama Institute, Suehiro, Tsurumi‐ku, Yokohama, Japan
  1. ↵*Corresponding author. Research Institute of Molecular Pathology, Vienna Biocenter, Dr. Bohr‐Gasse 7, 1030 Vienna, Austria. Tel.: +43 1 797 30 521; Fax: +43 1 798 87153; E-mail: wutz{at}imp.univie.ac.at
View Full Text
  • Article
  • Figures & Data
  • Transparent Process
Loading

Article Figures & Data

Figures

  • Tables
  • Supplementary Materials
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    PRC1 recruitment by Xist. (A) Overview of the inducible Xist expression system (TetOP) on chromosome 11 and the X in clone 36 and ΔSX ES cells, respectively. In clone 36 ES cells, Xist induction silences a linked puromycin marker gene (puro). In ΔSX cells, the A repeat of Xist (triangle) is deleted. (B) Recruitment of the PRC1 components Ring1b and Mph1 as well as resulting H2AK119ub1 was observed by combined Xist RNA FISH (red) and immunofluorescence analysis (green) in undifferentiated ΔSX ES cells after 3 days Xist induction. (C) H2AK119ub1 is regulated by a chromosomal memory in differentiated cells. Bar graphs representing the percentage of nuclei with focal H2AK119ub1 signals (grey bars) and Xist RNA (white bars) is given (above). Error bars represent the standard deviation. Below a scheme of the ES cell differentiation time course showing the presence (black) or absence (white) of doxycycline. An asterisk marks the Xist induction scheme revealing the chromosomal memory. (D) Analysis of H3K27me3 in parallel cultures to (C).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Generation of ES cells lacking Eed. (A) Northern analysis of Eed, Suz12 and Ezh2 in undifferentiated control clone 36 and Eed deficient 36Eed‐/‐ ES cells after Xist was induced for 3 days (+) or not (−); Gapdh as loading control. (B) Western analysis of Eed, Ezh2 and Suz12 in nuclear extracts from uninduced ES cells (−) or induced for 3 days (+). hnRNP A as loading control, asterisk indicates a nonspecific band. (C–E) Indirect immunofluorescence (green) of Eed (C), Ezh2 (D) or Suz12 (E) and subsequent Xist RNA FISH (red) of representative nuclei of undifferentiated 36Eed−/− and control clone 36 ES cells after 3 days of Xist induction. DAPI (blue) stains DNA. Statistics of the number of nuclei showing colocalisation of Suz12 staining with Xist in 36 and 36Eed−/− ES cells. Error bars indicate standard deviation (n>600).

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Histone modifications in Eed deficient ES cells. (A–E) Combined Xist RNA FISH (red) indirect immunofluorescence of indicated histone modifications (green) analysis on undifferentiated 36Eed−/− and control 36 ES cells after 3 days Xist expression. Representative images are shown, statistics see Table I. (F) Western analysis of mono‐, di‐ and tri‐methylation of H3K27 in 36Eed−/− clones 1 and 2 and control 36 ES cells after Xist induction for 3 days (+) or not (−); loading control hnRNP A. (G) Mass‐spectrometric analysis of histone H3 lysine 27 methylation in clone 36, 36Eed−/− and 36EedTG ES cells. The percentage of the indicated modification state is given for three independent experiments; error bars indicate standard deviation.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Recruitment of PRC1 components in the absence of Eed. (A, B) Indirect immunofluorescence (IF) of Ring1b (A), Mph1 (B) and subsequent Xist RNA FISH (red) analysis on undifferentiated 36Eed−/− and control clone 36 ES cells after Xist expression for 3 days. (C) Analysis for Mph2 in ES cells differentiated for 8 days in the presence of doxycycline. The percentage of nuclei showing focal IF staining colocalising with Xist RNA is given for undifferentiated (ES), day 3 (DD3) and day 8 (DD8) of differentiation. Error bars represent standard deviation (n>350).

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Initiation and maintenance of silencing independent of Eed. (A) Northern analysis of PGKpuromycin, (puro) silencing in 36Eed−/− and control clone 36 cells after Xist induction for 24, 48 and 72 h; Gapdh as loading control. (B) Maintenance of puro silencing in cells differentiated in the presence (+; lanes 2, 5 and 8) or absence (−; 1, 4 and 9) doxycycline, or differentiated for 4 days in the presence followed by 4 days in the absence of doxycycline (lanes 3, 6 and 7). (C) Northern analysis of puro expression in embryoid bodies outgrowths established in the presence of doxycycline (+) or without (−) after 4 weeks. (D) Quantitative expression analysis of Cct4, Npm1, Igf2b and Tk1 on chromosome 11 in control 36 and 36Eed‐/− ES cells at day 8 of differentiation in the absence (red bars), continuous presence (blue bars) of doxycycline, or presence of doxycycline for the first 4 days (green bars). Means of three independent measurements normalised to Gapdh are shown, error bars represent standard deviation. Scheme on the left shows the genes relative to the Xist transgene.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    A chromosomal memory independent of silencing and Eed. (A) The percentage of nuclei showing focal staining for H2AK119ub1 or H3K27me3 (grey bars) and Xist RNA (white bars) is given (above). Error bars represent the standard deviation. Underneath the ES cell differentiation time course is depicted and the presence (black) or absence (white) of doxycycline is indicated. The Xist induction scheme revealing a chromosomal memory for H2AK119ub1 and H3K27me3 is marked by an asterisk. (B) Summary of recruitment of PRC1 and PRC2 by Xist in X inactivation.

Tables

  • Figures
  • Supplementary Materials
  • Table 1. PcG proteins and histone modifications recruited by Xist
    EedEzh2Suz12Ring1bMph1Mph2*H3K27me3H4K20me1H2AK119ub1
    3689±3%79±9%88±3%56±7%48±11%33±8%96±1%82±13%97±2%
    n=624n=346n=629n=368n=502n=470n=346n=410n=488
    36Eed−/−0013±2%NDNDND050±10%98±0%
    Clone1n=510n>600n=624n>600n=227n=479
    36Eed−/−007±1%53±8%00036±7%ND
    Clone2n=634n>600n=629n=478n=650n=456n>600n=224
    • The percentage of focal signals colocalising with Xist RNA in ES cells treated with doxycycline for 3 days, or after 8 days of differentiation in the presence of doxycycline (*). Mean±s.d. of three independent slides and the total number of nuclei counted (n) are indicated.

Supplementary Materials

  • Figures
  • Tables
  • Supplementary Figure 1 [emboj7601187-sup-0001.pdf]

  • Supplementary Figure 2 [emboj7601187-sup-0002.pdf]

  • Supplementary Figure 3 [emboj7601187-sup-0003.pdf]

  • Supplementary Figure 4 [emboj7601187-sup-0004.pdf]

  • Supplementary Figure 5 [emboj7601187-sup-0005.pdf]

Previous Article in this IssueNext Article in this Issue
Back to top

  • PDF
  • Share
  • Export
  • Print
Loading

PDF

In this Issue
Volume 25, Issue 13
12 July 2006
The EMBO Journal: 25 (13)
Alert me when this article is cited
Alert me if a correction is posted

Article

  • Article
    • Abstract
    • Introduction
    • Results
    • Discussion
    • Materials and methods
    • Supplementary Information
    • Acknowledgements
    • References
  • Figures & Data
  • Transparent Process

Related Content

More Article

  • Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long‐QT syndrome
    Milena Bellin, Simona Casini, Richard P Davis, Cristina D'Aniello, Jessica Haas, Dorien Ward‐van Oostwaard, Leon G J Tertoolen, Christian B Jung, David A Elliott, Andrea Welling, Karl‐Ludwig Laugwitz, Alessandra Moretti, Christine L Mummery
    The EMBO Journal 32: 3161-3175
  • Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis
    Mircea Winter, Mirjam A Moser, Dominique Meunier, Carina Fischer, Georg Machat, Katharina Mattes, Beate M Lichtenberger, Reinhard Brunmeir, Simon Weissmann, Christina Murko, Christina Humer, Tina Meischel, Gerald Brosch, Patrick Matthias, Maria Sibilia, Christian Seiser
    The EMBO Journal 32: 3176-3191
  • Acetylation of p53 stimulates miRNA processing and determines cell survival following genotoxic stress
    Jonathan Chang, Brandi N Davis‐Dusenbery, Risa Kashima, Xuan Jiang, Nisha Marathe, Roberto Sessa, Justin Louie, Wei Gu, Giorgio Lagna, Akiko Hata
    The EMBO Journal 32: 3192-3205
More Article

Related Articles

Cited By...

Request Permissions

Subject Areas

  • Chromatin, Epigenetics, Genomics & Functional Genomics

Journal

  • Latest Online
  • Current Issue
  • Archive
  • Bibliometrics
  • E-Mail Editorial Office
  • Privacy Policy

Authors & Referees

  • Aims & Scope
  • Editors & Board
  • Transparent Process
  • Author Guidelines
  • Referee Guidelines
  • Open Access
  • Submit

Info

  • Alerts
  • RSS Feeds
  • Subscriptions & Access
  • Reprints & Permissions
  • Advertise & Sponsor
  • News & Press
  • Recommend to Librarian
  • Customer Service

EMBO

  • Funding & Awards
  • Events
  • Science Policy
  • Members
  • About EMBO

Online ISSN  1460-2075

Copyright© 2019 EMBO

This website is best viewed using the latest versions of all modern web browsers. Older browsers may not display correctly.